or Try an Advanced Search...

    Precision Medicine Stocks List

    Symbol Grade Name % Change
    EXAI F Exscientia Limited -8.25
    AVTX D Avalo Therapeutics, Inc. -6.69
    RLAY F Relay Therapeutics, Inc. -0.56
    FUSN A Fusion Pharmaceuticals Inc. -0.19
    GTH B Genetron Holdings Limited 0.00
    PRAX B Praxis Precision Medicines, Inc. 0.70
    WGS B GeneDx Holdings Corp. 0.82
    NTLA F Intellia Therapeutics, Inc. 1.42
    CRSP F CRISPR Therapeutics AG 1.49
    GH D Guardant Health, Inc. 1.61
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
    Related Stock Lists: Biology Evidence Based Medicine Medicine Molecular Biology Systems Biology Biopharmaceutical CRISPR Cancer Cas9 Clinical Development Drug Discovery Emerging Technologies Enzymes Fibroblast Growth Factor Fibroblast Growth Factor Receptor Genetics Genome Editing Immune System Oncology Solid Tumors

    Related ETFs - A few ETFs which own one or more of the above listed Precision Medicine stocks.

    Symbol Grade Name Weight
    ARKG D ARK Genomic Revolution Multi-Sector ETF 11.44
    GNOM D Global X Genomics & Biotechnology ETF 8.14
    ARKK D ARK Innovation ETF 7.0
    NXTE C AXS Green Alpha ETF 4.97
    MEDX F Horizon Kinetics Medical ETF 4.06
    View all Precision Medicine ETFs...
    Compare ETFs
    Compare ARKG to MEDX Compare GNOM to NXTE Compare NXTE to MEDX

        Precision Medicine Stocks Recent News

        Date Stock Title
        May 3 NTLA Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
        May 3 CRSP CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know
        May 3 CRSP Crispr Therapeutics: Market Misunderstanding Is Your Buying Opportunity (Upgrade)
        May 3 NTLA IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 3 RLAY Relay Therapeutics GAAP EPS of -$0.62 beats by $0.10, revenue of $10.01M beats by $9.09M
        May 2 RLAY Relay Therapeutics Outperforms Revenue Expectations in Q1 2024
        May 2 RLAY Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
        May 2 RLAY Relay Therapeutics GAAP EPS of -$0.62 beats by $0.08, revenue of $10M beats by $9.89M
        May 2 RLAY Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
        May 2 FUSN Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 PRAX Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
        May 2 NTLA Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
        May 2 WGS GeneDx Holdings Corp. (NASDAQ:WGS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
        May 2 CRSP 3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
        May 1 WGS GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript
        May 1 CRSP Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
        May 1 WGS GeneDx Holdings First Quarter 2024 Earnings: Beats Expectations
        Apr 30 CRSP Invest In A Revolutionary Gene Therapy With CRISPR Therapeutics
        Apr 30 WGS GeneDx Holdings Corp (WGS) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues and ...
        Apr 30 WGS GeneDx Holdings Corp. (WGS) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
        Related Stock Lists: Biology Biotechnology Medicine Systems Biology Cancer Disease Immune System Biomarkers CRISPR Cancer Treatment Cas9 Checkpoint Inhibitor Clinical Development Evidence Based Medicine Genetics Genome Editing Molecular Biology Oncology Solid Tumors Targeted Therapy
        Precision Medicine

        Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

        More about Precision Medicine
        Browse All Tags